首页|期刊导航|中华医学杂志（英文版）|Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway

Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway

Qiong Li Lei Gao Cheng Yang Lingyi Rao Li Gao Xi Zhang Jun Rao Naya Ma Xinlei Li Chao Yang Wei Zhang Jingkang Xiong Lidan Zhu Jiali Li Qin Wen

中华医学杂志（英文版）2023，Vol.136Issue(12)：1448-1458,11.

中华医学杂志（英文版）2023，Vol.136Issue(12)：1448-1458,11.DOI:10.1097/CM9.0000000000002686

Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway

Qiong Li ¹Lei Gao ²Cheng Yang ²Lingyi Rao ²Li Gao ²Xi Zhang ¹Jun Rao ¹Naya Ma ²Xinlei Li ²Chao Yang ²Wei Zhang ²Jingkang Xiong ²Lidan Zhu ²Jiali Li ²Qin Wen²

作者信息

1. Medical Center of Hematology,Xinqiao Hospital,Army Medical University,Chongqing 400037,China||State Key Laboratory of Trauma,Burns and Combined Injury,Army Medical University,Chongqing 400037,China||National Clinical Research Center for Hematologic Diseases,the First Affiliated Hospital of Soochow University,Suzhou 215123,China
2. Medical Center of Hematology,Xinqiao Hospital,Army Medical University,Chongqing 400037,China||State Key Laboratory of Trauma,Burns and Combined Injury,Army Medical University,Chongqing 400037,China
折叠

摘要

关键词

Lymphoma,large B-cell,diffuse/Rituximab resistance/Apoptosis,WW domain-containing transcription regulator protein 1

Key words

Lymphoma,large B-cell,diffuse/Rituximab resistance/Apoptosis,WW domain-containing transcription regulator protein 1

引用本文复制引用

Qiong Li,Lei Gao,Cheng Yang,Lingyi Rao,Li Gao,Xi Zhang,Jun Rao,Naya Ma,Xinlei Li,Chao Yang,Wei Zhang,Jingkang Xiong,Lidan Zhu,Jiali Li,Qin Wen..Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway[J].中华医学杂志（英文版）,2023,136(12):1448-1458,11.

基金项目

This study was supported by grants from the National Natural Science Fund(No.82070208),National Natural Science Foundation of Chongqing(cstc2020jcyjm-sxmX0433),the Major program of Chongqing Health Commission and Science and Technology Bureau Joint project(2022DBXM003),Chongqing Science and Health Joint medical research project(2023QNXM047),Military clinical medical innovation project of Xinqiao hospital(2021JSLC0003),the Science and technology innovation promotion project of AMU(2019XLC3020),and the Translational Research Grant of NCRCH(2020ZKZC02 and 2021WWB05). （No.82070208）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航